| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6826205 | Schizophrenia Research | 2013 | 7 Pages |
Abstract
The utility of therapeutic drug monitoring of SGAs (other than clozapine) remains an open question, although limited evidence from fixed-dose studies is encouraging. We discuss the potentially significant clinical value of antipsychotic Cps and the consequent need for further research in this area.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Leonardo V. Lopez, John M. Kane,